Lack of one nutrient 'shortens life worse than smoking', says doctor
A lack of omega-3 oil in the diet can shorten life even more than smoking, warns new research. Scientists found that smoking knocked four years off life expectancy whereas low levels of the fatty acid - found in oily fish such as salmon and mackerel - could reduce it by five years.
The oil is known to be good for the heart and reduces blood clots. A good level is eight per cent or higher, intermediate is between four and eight per cent and low is four per cent and below.
Study lead researcher Dr Michael McBurney, of the University of Guelph in Canada, said: "It is interesting to note that in Japan, where the mean Omega-3 Index is greater than eight per cent, the expected life span is around five years longer than it is in the United States, where the mean Omega-3 Index is about five per cent.
READ MORE: Reduce cholesterol by eating 1 type of food – it'll make a 'big difference'
READ MORE: Fat in common cooking oils linked to aggressive breast cancer
"Hence, in practice, dietary choices that change the Omega-3 Index may prolong life. In the final combined model, smoking and the Omega-3 Index seem to be the most easily modified risk factors. Being a current smoker, at age 65, is predicted to subtract more than four years of life, compared with not smoking, a life shortening equivalent to having a low vs. a high Omega-3 Index."
The study, published in the American Journal of Clinical Nutrition, used statistics from the Framingham Heart Study, one of the longest running studies in the world.
The FHS provided unique insights into cardiovascular disease risk factors and led to the development of the Framingham Risk Score based on eight baseline standard risk factors--age, sex, smoking, hypertension treatment, diabetes status, systolic blood pressure, total cholesterol (TC), and HDL cholesterol.
Researchers in the study found that measuring fatty acids could predict mortality similarly to standard risk factors. Co-author Dr Bill Harris, President of the Fatty Acid Research Institute, said: "The information carried in the concentrations of four red blood cell fatty acids was as useful as that carried in lipid levels, blood pressure, smoking, and diabetic status with regard to predicting total mortality.
'This speaks to the power of the Omega-3 Index as a risk factor and should be considered just as important as the other established risk factors, and maybe even more so."
Risk can be reduced by changing factors like diet, tobacco, alcohol and physical inactivity. Researchers in the study discovered lifestyle choices could help identify those at risk. It could also be useful to prevent ill health, delay death and do treatment approach assessments.
A previous 2018 report of 2500 participants in the Framingham Offspring Cohort found individuals with a high Omega 3 index were 33 per cent less likely to die. Similar connections have been found in the Women's Health Initiative Memory Study, Heart and Soul Study and the Ludwigshafen Risk and Cardiovascular Health Study.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a day ago
- Yahoo
6 benefits of vitamin D from slowing down ageing to boosting immunity
Taking regular vitamin D supplements could slow down biological ageing, according to a new study. The trial, published by the American Journal of Clinical Nutrition, found that not only did those taking the vitamin every day see less age-related damage to their DNA, the supplement could "prevent the equivalent of nearly three years of ageing" when taken over the course of four years. Vitamin D supplements are said by the authors of the study to be a "promising strategy to counter biological ageing", that could also help lower the risk of various diseases, such as Alzheimer's, dementia and some cancers. Here, we take a look at the other benefits and potential side-effects of vitamin D, which is made naturally by our bodies in sunlight, and found in a small number of foods such as oily fish, red meat, egg yolks, liver and fortified cereal as well as supplements. Not only does vitamin D help with bone development and maintenance, it regulates the body's calcium and phosphate levels, making sure you get enough nutrients to keep your bones, teeth and muscles healthy. Too much calcium (also known as hypercalcemia) can cause stomach upset, vomiting and constipation – while too little (hypocalcemia) can cause spasms, muscle cramps, numbness in the hands, arms, feet and legs. Over time, a calcium deficiency can lead to brittle bones, dry skin, broken or brittle nails and coarse hair, among other things. Phosphate, meanwhile, helps maintain the integrity of cell membrane, promotes bone and teeth growth and health, and is essential for the production of energy, muscle and nerve function. A 2015 study part-funded by the British Heart Foundation found that having low levels of vitamin D could be associated with an increased risk of cardiovascular disease. Though, it points out, low vitamin D is a result of lifestyle factors, rather than the cause of increased risk. Too much vitamin D, however, can have an adverse affect on the heart, as high levels of calcium can cause heart palpitations, hypercalcemia (as mentioned above) and even increase the risk of coronary artery disease (CAD) – which, in turn, may lead to a heart attack or congestive heart failure. Those with low levels of vitamin D have been shown to be more susceptible to autoimmune and infectious diseases, like rheumatoid arthritis, multiple sclerosis (MS) and type 1 diabetes. A 2021 medical review, looking at various studies that suggest low vitamin D is associated with obesity, found there is a link between vitamin D levels and body weight. However it said interventional studies do not support a beneficial effect of vitamin D supplementation on body weight and that more evidence is needed to suggest a casual link between the vitamin and weight management. According to a paper published in 2022, low vitamin D levels are associated with increased depressive symptoms, as well as anxiety. It went on to say that, because of its antioxidant properties and activity in brain tissue, vitamin D is important in the treatment and prevention of mood disorders. The official guidelines provided by the UK government state that everyone should aim to have a daily vitamin D supplement during the autumn and winter. As the sun is a source of vitamin D, most of us don't need to take supplements in the warmer months. However, official advice is that for those at risk of not getting enough vitamin D – such as children aged 1-4 and babies – should take a daily supplement all year round. Signs of a vitamin D deficiency include fatigue, muscle ache, bone and lower back pain and hair loss, among other things. Severe deficiency of vitamin D can also result in rickets in children and osteomalacia in adults. You can find out more here. sunlight oily fish (like salmon, sardines, herring and mackerel) red meat liver egg yolks fortified foods (like some fat spreads and breakfast cereals) Read more about health and nutrition How sudden weather changes affect your mood and health, according to an expert (Yahoo Life UK, 4-min read) 5 health benefits of strawberries as UK sees giant fruit you 'cannot fit in your mouth' (Yahoo Life UK, 4-min read) I have coeliac disease – here's what no one tells you about going gluten-free (Yahoo Life UK, 7-min read)
Yahoo
3 days ago
- Yahoo
This Government-Funded Snack From The '60s Was Originally Made For Astronauts
Back when going to the moon was the world's hottest topic, companies were doing whatever they could to get a piece of the pie. Brands were sending their products straight to space, and customers were eating it up. Omega debuted a watch fit for spacewalkers, and Tang pushed advertisements for space-approved soda, but Pillsbury — under contract with the U.S. government — was more focused on the astronauts heading to the stars than the consumers on the ground. Pillsbury was tasked with creating the first space-safe solid food by none other than the Quartermaster Food and Container Institute of the United States Armed Forces in the early '60s. The company started with teeny condensed food cubes, which were chowed down by NASA astronaut Scott Carpenter on the Aurora 7 in the summer of 1962. A few years later, NASA had another assignment for Pillsbury: create an energizing snack that could fit through an astronaut's helmet. The airtight suits didn't make it easy, but Pillsbury delivered with Space Food Sticks. The nutrient-packed snack was like a chewy chocolate power bar squeezed into a thin tube, which made it a hit for not just astronauts but growing kids everywhere. Before it was a popular lunchbox snack, Space Food Sticks accompanied Buzz Aldrin and Neil Armstrong to the moon in 1969. Read more: 15 Vintage Snacks No One Remembers Anymore The energizing snack may have been made exclusively for astronauts, but it was a far bigger hit on Earth. Early advertisements for Space Food Sticks declared they were "developed by Pillsbury under a government contract, in support of the U.S. aerospace program" — but that language didn't last long. Into the next decade, Pillsbury began running ad campaigns for the astronaut-endorsed snack, but more geared towards Earthbound folks. The concept of Space Food Sticks integrated seamlessly with the other space-themed commercials of the time, making them an instant sensation. In later ads, Pillsbury kept it simple, labeling Space Food Sticks as a "balanced nutrition snack." Buzz and Armstrong only got a taste of the original chocolate flavor, but Pillsbury introduced dozens of other varieties over the years. Each flavor seemed to hang onto the "chewy" descriptor, with added flavors like peanut butter, orange, caramel, and chocolate mint. There are dozens of vintage snacks that no one really remembers anymore, but Space Food Sticks should never be forgotten. Only a few years after they were introduced, Pillsbury dropped the word "space" from the label, shortening them to just Food Sticks, but the legacy lives on. Read the original article on Tasting Table.
Yahoo
5 days ago
- Yahoo
UT Health San Antonio researchers discover new links between heart disease and dementia
Research led by The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has discovered new associations between various lipid, or fat, levels in the blood and the risk of developing Alzheimer's disease. SAN ANTONIO, May 30, 2025 /PRNewswire-PRWeb/ -- People who are at higher risk for heart disease also seem more likely to develop dementia. And research led by The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has discovered new associations between various lipid, or fat, levels in the blood and the risk of developing Alzheimer's disease, the most common cause of dementia worldwide. The findings mean that using blood lipid profiles could help better understand, predict and possibly even prevent the disease in the future. In more than 800 older adults who were part of the long-running Framingham Heart Study, the researchers found that higher levels of small dense cholesterol particles – which are known to increase the risk of atherosclerosis and coronary heart disease – were associated with higher risk of developing Alzheimer's disease. However, higher levels of a marker for small fat-carrying particles, which are involved in the transport of dietary fats from the gut to other body tissues through the blood after eating, were associated with lower risk of developing the disease. Perhaps ironically, the researchers also discovered that individuals who had the lowest levels of highly dense cholesterol particles – often referred to as "good cholesterol" as it is considered protective against cardiovascular disease – had a lower risk of developing Alzheimer's disease compared to the rest of the included individuals. "These findings highlight the complex relationships of blood lipids with both heart and brain health, suggesting the possibility of certain blood lipids playing different roles in cardiovascular disease and dementia-related biological processes," said Sokratis Charisis, MD, a researcher with the Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases at UT Health San Antonio. Charisis is first author of the study published May 30 in the journal Neurology, titled, "Association of Blood Lipoprotein Levels With Incident Alzheimer's Disease in Community-Dwelling Individuals: The Framingham Heart Study." Other authors include corresponding author Sudha Seshadri, MD, director of the Biggs Institute, and researchers from Boston University School of Public Health, the University of Texas Rio Grande Valley and the Framingham Heart Study. A community-based analysis The new study notes that dementia is a leading source of morbidity and mortality in the aging population. Worldwide, there were 57.4 million people living with dementia in 2019, a number that is expected to reach 152.8 million by 2050. However, there is a general trend over time of decreasing incidence of Alzheimer's disease and other dementias in the U.S. and other higher-income countries that is at least partially attributed to better management of cardiovascular risk factors. The Framingham Heart Study is an ongoing, community-based cohort study that was launched in 1948 in Framingham, Massachusetts. Residents there ages 30 to 59 were randomly selected from census data to participate. Those with definite signs of cardiovascular disease at baseline were excluded. Participants of the original cohort have undergone up to 32 examinations performed every two years, which have included detailed history-taking by a physician, a physical examination and lab testing. The latest analysis by researchers led by UT Health San Antonio included participants from the original cohort who were 60 years or older and free of dementia during an examination period of 1985-1988, and had available cognitive follow-up and lipoprotein marker data. Lipoproteins act as a transport system for lipids in the bloodstream. Blood lipid levels and dementia Levels of high-density lipoprotein cholesterol (HDL-C), or good cholesterol; low-density lipoprotein cholesterol (LDL-C), or "bad cholesterol"; small dense LDL-C (sdLDL-C); and other lipoprotein types associated with heart disease were measured in blood samples obtained from the mid- to late-'80s examination period. The Framingham participants were watched for incident Alzheimer's disease, meaning a first diagnosis of the disease, until 2020. Of a total of 822 participants, 128 developed incident Alzheimer's disease. The researchers discovered that an increase of 1 standard deviation unit (SDU) of a concentration of small dense LDL-C (sdLDL-C), a value representing how far a specific data point deviates from the mean, was associated with a 21% increase in the risk for incident Alzheimer's disease. As the name implies, small dense LDL-C (sdLDL-C) is a type of the so-called bad cholesterol with smaller and denser particles than other low-density lipoproteins, and that is considered more likely to form plaque in arteries, strongly associated with an increased risk of atherosclerotic cardiovascular disease. A 1 SDU increase in a concentration of ApoB48, a lipoprotein that transports dietary fat from the intestines and into the bloodstream that also is tied to heart disease and cardiovascular problems, was found to be associated with a 22% decrease in the risk for incident Alzheimer's disease. Participants in the first quartile of HDL-C, or good cholesterol – in order of lesser amounts – were 44% less likely to develop Alzheimer's compared with those in the second, third and fourth quartiles. And those with small dense LDL-C concentrations below the median were 38% less likely to develop Alzheimer's compared with those with concentrations above the median. In summary, then, lower small-density bad cholesterol (sdLDL-C) concentrations and higher ApoB48 concentrations were associated with a lower Alzheimer's risk. And individuals with the lowest good cholesterol (HDL-C) concentrations were less likely to develop Alzheimer's compared with the remaining sample. "These findings underscore links between lipoprotein metabolism pathways and Alzheimer's risk, emphasizing the potential role of blood lipoprotein markers in Alzheimer's risk stratification and of lipid modification strategies in dementia prevention," the researchers concluded. Association of Blood Lipoprotein Levels With Incident Alzheimer's Disease in Community-Dwelling Individuals: The Framingham Heart Study Sokratis Charisis, Sophia Lu, Jesus David Melgarejo, Claudia L. Satizabal, Ramachandran S. Vasan, Alexa S. Beiser, Sudha Seshadri First published: May 30, 2025, in the journal Neurology Link to full study: The University of Texas Health Science Center at San Antonio (UT Health San Antonio), a primary driver of San Antonio's $44.1 billion health care and biosciences sector, is the largest academic research institution in South Texas with an annual research portfolio of more than $436 million. Driving substantial economic impact with its six professional schools, a diverse workforce of more than 9,400, an annual expense budget of $1.67 billion and clinical practices that provide 2.5 million patient visits each year, UT Health San Antonio plans continued growth over the next five years and anticipates adding more than 1,500 higher-wage jobs to serve San Antonio, Bexar County and the South Texas region. To learn about the many ways "We make lives better®," visit The Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases is dedicated to providing comprehensive dementia care while advancing treatment through clinical trials and research. The Biggs Institute is a National Institute on Aging (NIA)-designated Alzheimer's Disease Research Center (ADRC). In addition to patient care and research, the Biggs Institute partners with the School of Nursing at UT Health Science Center San Antonio to offer the Caring for the Caregiver program. Stay connected with The University of Texas Health Science Center at San Antonio on Facebook, Twitter, LinkedIn, Instagram and YouTube. Media Contact Steven Lee, 2104503823, lees22@ View original content: SOURCE
